The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Assessment of Disparities in Digital Access Among Medicare Beneficiaries and Implications for Telemedicine
Open accessAbstract
quine from retail pharmacies, including an approximate additional 93 000 patients who received both hydroxychloroquine and azithromycin.First, evidence of efficacy in preventing or treating COVID-19 is limited.Treatment guidelines found insufficient clinical data to recommend for or against hydroxychloroquine or chloroquine use and recommend against combining either with azithromycin, except in clinical trials. 1 Second, because of reports of cardiac and other adverse events, the US Food and Drug Administration has cautioned against using hydroxychloroquine or chloroquine for COVID-19 outside of hospitalized settings or clinical trials.5 If azithromycin is used with hydroxychloroquine or chloroquine, correcting electrolyte levels, completing electrocardiographic monitoring, and avoiding other QTc interval-prolonging drugs are recommended.6 Third, sudden increases in demand for hydroxychloroquine and chloroquine limit availability for FDAapproved uses for rheumatoid arthritis, lupus, and malaria.5 While some of the largest increases in hydroxychloroquine and chloroquine dispensing occurred in states with high COVID-19 case rates (eg, New Jersey, New York), other states with large increases in dispensing had moderate (eg, Florida) or low (eg, Hawaii) case rates.These data do not include prescribing indication, so not all increased dispensing may be for COVID-19.It is unknown if patients immediately used or saved these medications.Finally, data were collected prior to release of many treatment guidelines and as state board of pharmacy dispensing regulations for hydroxychloroquine and chloroquine were evolving.2 As COVID-19 continues to spread, ongoing assessment of the use of potential therapies will be essential to inform safe and appropriate treatment, along with prompt adverse event reporting to FDA's MedWatch safety reporting program (https:// www.fda.gov/safety/medwatch-fda-safety-information-and- adverse-event-reporting-program).State-specific data can help target efforts to improve prescribing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Federal Communications Commission
(2015) · The Encyclopedia of Civil Liberties in America · doi:10.4324/9781315699868-248 · Cited by 1,558
Telemedicine: Where It Is and Where It's Going
Grigsby, J., & Sanders, J. H. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-2-199807150-00012 · Cited by 180
Mehrotra, A., Huskamp, H. A., Souza, J., Uscher-Pines, L., Rose, S., Landon, B. E., Jena, A. B., & Busch, A. B. (2017) · Health Affairs · doi:10.1377/hlthaff.2016.1461 · Cited by 158
Self-citation
Cited by
Torous, J., Bucci, S., Bell, I. H., Kessing, L. V., Faurholt‐Jepsen, M., Whelan, P., Carvalho, A. F., Keshavan, M., Linardon, J., & Firth, J. (2021) · World Psychiatry · doi:10.1002/wps.20883 · Cited by 1,199
Patel, S. Y., Mehrotra, A., Huskamp, H. A., Uscher-Pines, L., Ganguli, I., & Barnett, M. L. (2021) · Health Affairs · doi:10.1377/hlthaff.2020.01786 · Cited by 453
Self-citationA Qualitative Study of Primary Care Physicians’ Experiences With Telemedicine During COVID-19
Gomez, T., Anaya, Y. B., Shih, K. J., & Tarn, D. M. (2021) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2021.s1.200517 · Cited by 310
Badr, J., Motulsky, A., & Denis, J.-L. (2024) · Health Policy · doi:10.1016/j.healthpol.2024.105122 · Cited by 283
Mao, A., Tam, L., Xu, A., Osborn, K., Sheffrin, M., Gould, C., Schillinger, E., Martin, M., & Mesias, M. (2022) · JMIR Aging · doi:10.2196/34326 · Cited by 136
Metadata
- Authors
- Roberts, E. T., & Mehrotra, A.
- Venue
- JAMA Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2020-10-01
- Volume
- 180
- Issue
- 10
- Pages
- 1386
- ISSN
- 2168-6106 (ISSN-L)
- OpenAlex
- W3046994664
- Cited by
- 353
- References
- 3
- FWCI
- 40.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assessment of Disparities in Digital Access Among Medicare Beneficiaries and Implications for Telemedicine. https://app.cochat.ai/papers/10.1001/jamainternmed.2020.2666
- The paper
- Roberts, E. T., & Mehrotra, A. (2020). Assessment of Disparities in Digital Access Among Medicare Beneficiaries and Implications for Telemedicine. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2020.2666
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.